🚨Announcement: Authors employed by the U.S. federal gov't are eligible for 1 free publication in @InnoJournals. Submit before 12/31. This includes the following titles: @JIPOEditors @JQSHEditors @EditorsIddb @EditorsIsim @ASRHEditors

Hear directly from science and business stakeholders on the latest data impacting #ImmunoOncology at the 12th Annual #IO360. Save 20% when you register with code JIPO20 https://t.co/jOCVJAEXNS

Would you like to speak at a #immunotherapy & #preciononcology conference? We're accepting submissions of research and case report abstracts to be presented at #IPOF2026! Submit by Jan 31 https://t.co/HL22nRb2Fg @DoubaZain @debel526895 @ANaingMD @OncologyNetwork

Commentary by Sheshadri et al. discusses "Antibody-Drug Conjugate–Induced Pneumonitis: A Growing Threat" https://t.co/bWU3plbn8P #JIPO #NSCLC #Pneumonitis @OncologyNetwork

Limaye et al. report on a case which challenges the conventional paradigm that EGFR-mutated NSCLC does not benefit from immunotherapy https://t.co/I7DRayXPFX #immunotherapy #precisiononcology @OncologyNetwork

Brand new call for papers with #JIPO: Submit your work related to AI in Immunotherapy, Precision Oncology, & Clinical Trials: https://t.co/I5b7MMlnsm #aiimmunotherapy #aioncology #aihealthcare @InnoJournals @OncologyNetwork

Watson et al. review the combination of targeted therapies and immunotherapies for advanced and metastatic sarcomas, in #JIPO review article https://t.co/EgzkX48Nf6 #sarcoma #targetedtherapies @OncologyNetwork

November is #LungCancerAwarenessMonth. At #JIPO we dedicate our journal to #precisiononcology. Review one of our recent review articles by AlJassim et al. which dives into #LungCancer treatments in the MENA region https://t.co/XM8c3SBoio #NSCLC @OncologyNetwork

In this new #JIPO brief report learn "Characterizing Inquiries About Novel Cancer Therapies" by Vanderpool et al. https://t.co/8FhnzL08lr #cancertreatment #precisiononcology @DoubaZain @debel526895 @ANaingMD @OncologyNetwork

New research article by Habra et al. "Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma" https://t.co/a0wA92dLaD #JIPO #Adrenocorticalcarcinoma, #AntiPDL1 #immunotherapy #pembrolizumab @DoubaZain @ANaingMD @OncologyNetwork

#JIPO case report by Demiray et al. "Exceptional response in a patient with mRCC through precision-guided treatment involving immunotherapy rechallenge with temsirolimus and bevacizumab" https://t.co/ZVf0rhyJY0 #immunotherapy

Sheshadri et al. comments on recent case report "Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis w/ Novel Steroid Regimen in NSC Lung Cancer" https://t.co/bWU3plbn8P #JIPO #NSCLC #Pneumonitis @ajaysheshadri @DoubaZain @ANaingMD @OncologyNetwork

#JIPO case report by Fox et al. "Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non–Small Cell Lung Cancer" #ADC #NSCLC https://t.co/EX8pHXHway @DavidHongMD

#JIPO commentary explores "Selinexor in Uveal Melanoma: A Hopeful Step or Just Another Hurdle?" by Ayala de Miguel and Rolfo https://t.co/J9rX11iTgC #melanoma #selinexor #JIPO @ChristianRolfo

#JIPO commentary by Shroff and Brar discuss the use of Anti-PD-1 therapy for advanced #cholangiocarcinoma and its impacts https://t.co/dY8FLAVlpm #precisiononcology @ANaingMD @DoubaZain @OncologyNetwork

Today is #NationalMammographyDay. At #JIPO we're dedicated to advancing precision oncology. Let's all do our part in #breastcancer prevention and awareness. Learn more https://t.co/xkuJxFovb3 #MammographyAwareness

Would you like to speak at a #immunotherapy & #preciononcology conference? We're accepting submissions of research and case report abstracts to be presented at #IPOF2026! Submit by Jan 31 https://t.co/HL22nRbAuO @DoubaZain @ANaingMD @OncologyNetwork

Have you read our most recent #JIPO issue? Check it out: https://t.co/S7yxEwWAuk @InnoJournals #oncology #precisiononcology #immunotherapy

Brand new review by AlJassim et al. explores "Prevalence of Molecular Mutations in Non-Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region" https://t.co/XM8c3SAQsQ #JIPO #NSCLC #precisiononcology @DrZ_84 @DoubaZain @ANaingMD @OncologyNetwork

Lu et al. discuss IgG Therapy, which can be used to treat #immunodeficiencies, and provide a concise update the therapy, it's potential, as well as the hidden costs of this treatment. Read the commentary: https://t.co/gZgKRYSlAC #immunoglobulin #autoimmunedisorders #JIPO